Enanta Pharmaceuticals Stock Price and Value Analysis

Should you buy Enanta Pharmaceuticals stock? (NasdaqGS:ENTA). Let's see how it does in our automated value investing analysis system.

ENTA Free Cash Flow Trend

Free Cash Flow trendline for ENTA
Free Cash Flow trendline for Enanta Pharmaceuticals

Based on historical returns, we believe that Enanta Pharmaceuticals can grow its free cash at a rate of about 4%. That's positive!

  • This company is making money at a modest rate.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ENTA Numbers

ENTA Price
(Enanta Pharmaceuticals stock price per share)
[?] ENTA Fair Price
(based on intrinsic value)
[?] ENTA Safety Price (based on a variable margin of safety) $12.01
[?] PE Ratio versus Sector 16% higher than other Healthcare stocks
[?] PE Ratio versus Industry 59% lower than other Biotechnology stocks
[?] Free Cash Flow Jitter 56%

Is Enanta Pharmaceuticals Stock on Sale?

We believe that Enanta Pharmaceuticals may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Enanta Pharmaceuticals looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy ENTA Stock?

Does Enanta Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.